NCT01175330

Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting

Randomized Trial of Fish Oil Infusion to Prevent Atrial Fibrillation After Cardiac Surgery

• Status: Terminated
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 39 (actual)
• Sponsor: Meshalkin Research Institute of Pathology of Circulation · Network
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate efficacy of Polyunsaturated Fatty Acid for the prevention of Atrial Fibrillation and anti-inflammatory effects in patients after CABG surgery

Conditions

• Ischemic Heart Disease
• Atrial Fibrillation

Interventions

Type	Name	Description
DRUG	Omega-3 fish oil emulsion (Omegaven)	Lipid emulsion (omegaven) for intravenous use, 1 ml/kg/day daily for 7 days post-surgery period (The first infusion beginning in operative period)
DRUG	Intralipid	Lipid emulsion (Intralipid) for intravenous use, 1 ml/kg/day daily for 7 days post-surgery period (The first infusion beginning in operative period)

Timeline

• Start date: 2010-08-01
• Primary completion: 2012-12-01
• Completion: 2013-08-01
• First posted: 2010-08-04
• Last updated: 2015-03-24

Locations

1 site across 1 country: Russia